Hr Library

BioXcel announces job cuts to focus on agitation related treatment, ETHRWorld


hr.economictimes.indiatimes.com | www.ETHRWorld.com

<p>Shares of the company were halted during premarket trading.<br /></p>
Shares of the company were halted during premarket trading.

(Adds details in paragraphs 2)

BioXcel Therapeutics Inc said on Monday it will reduce its workforce to 80 employees from about 190, as the drugmaker shifts its focus to treatments for agitation.

The company said it will prioritize development of its drug BXCL501, being evaluated for use in at-home settings for treatment of agitation related to schizophrenia, bipolar disorders and in patients with mild-to-moderate dementia due to probable Alzheimer’s disease.

Shares of the company were halted during premarket trading. (Reporting by Sriparna Roy in Bengaluru; Editing by Krishna Chandra Eluri)

    Join the community of 2M+ industry professionals

    Subscribe to our newsletter to get latest insights & analysis.

    Download ETHRWorld App


Click Here to Read more /Source link

Show More

Related Articles

Back to top button